Archives: Agenda

As oncology trials grow more complex, speed is increasingly determined by decisions made early — during protocol design, feasibility, and site engagement. This fireside chat explores how closer collaboration between sponsors, CROs, and sites can improve execution, accelerate activation, and sustain trial momentum without sacrificing scientific rigor.

Discussion highlights include:

• Designing operationally realistic oncology protocols
• Gaining meaningful feasibility insight from sites
• Engaging sites as strategic partners
• Reducing downstream friction through early alignment
• Real‑world lessons from U.S. and European oncology trials

• Ensuring effective communication with patient populations to raise awareness of your trial and increase engagement
• Providing adequate material to ensure patients feel fully informed and supported during enrollment processes
• Driving patient-focused recruitment strategies to reduce study timelines

• Limitations in translational models, and implementing designs to succeed in trial
• Balancing the risk and reward for patients to attain key endpoints while building the exploratory
• Adaptive trial designs to accommodate changes in treatment paradigms

• • ‘Lab-in-the-loop’ approaches: integrating AI models and experimental platforms for target discovery and precision medicine
  • AI enabled precision oncology: biomarkers, patient stratification and clinical trial design 

• Understanding the Pharmacy Card Model
• The Program Lifecycle: From Design to Delivery
• A Day in the Life: Sponsor & Sites
• Proof of Performance: Feedback and Case Studies

• Cultural and behavioral dynamics
• Differing incentives and pressures
• Communication failures during safety events
• Building trust under time pressure